<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-03373892</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-19T06:50:15+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">War on Diseases. Patient Organizations' Problematization and Exploration of Market Issues</title>
            <author role="aut">
              <persName>
                <forename type="first">Vololona</forename>
                <surname>Rabeharisoa</surname>
              </persName>
              <email type="md5">b91e9a9abf2d5e1209202fa877a07534</email>
              <email type="domain">mines-paristech.fr</email>
              <idno type="idhal" notation="string">vololona-rabeharisoa</idno>
              <idno type="idhal" notation="numeric">13140</idno>
              <idno type="halauthorid" notation="string">9444-13140</idno>
              <idno type="IDREF">https://www.idref.fr/052263576</idno>
              <affiliation ref="#struct-445513"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Liliana</forename>
                <surname>Doganova</surname>
              </persName>
              <email type="md5">d601502603a515a3decb33c65cf8226b</email>
              <email type="domain">mines-paristech.fr</email>
              <idno type="idhal" notation="string">liliana-doganova</idno>
              <idno type="idhal" notation="numeric">12270</idno>
              <idno type="halauthorid" notation="string">7885-12270</idno>
              <idno type="IDREF">https://www.idref.fr/151853096</idno>
              <affiliation ref="#struct-445513"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Catherine</forename>
                <surname>Lucas</surname>
              </persName>
              <email type="md5">9fa1cfb53171c1a4374b0b65fa3aac69</email>
              <email type="domain">mines-paristech.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2021-10-11 17:12:04</date>
              <date type="whenModified">2026-02-07 05:21:54</date>
              <date type="whenReleased">2021-10-11 17:12:04</date>
              <date type="whenProduced">2021</date>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="143237">
                <persName>
                  <forename>Catherine</forename>
                  <surname>Lucas</surname>
                </persName>
                <email type="md5">9fa1cfb53171c1a4374b0b65fa3aac69</email>
                <email type="domain">mines-paristech.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-03373892</idno>
            <idno type="halUri">https://minesparis-psl.hal.science/hal-03373892</idno>
            <idno type="halBibtex">rabeharisoa:hal-03373892</idno>
            <idno type="halRefHtml">Susi Geiger. &lt;i&gt;Healthcare activism. Markets, Morals, and the Collective Goods&lt;/i&gt;, Oxford University Press, pp.55-85, 2021</idno>
            <idno type="halRef">Susi Geiger. Healthcare activism. Markets, Morals, and the Collective Goods, Oxford University Press, pp.55-85, 2021</idno>
            <availability status="restricted"/>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="SHS">Sciences de l'Homme et de la Société</idno>
            <idno type="stamp" n="ENSMP" corresp="PARISTECH">MINES ParisTech</idno>
            <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
            <idno type="stamp" n="AO-SOCIOLOGIE">Archives ouvertes de la Sociologie</idno>
            <idno type="stamp" n="ENSMP_CSI" corresp="ENSMP">Sociologie de l'innovation (CSI)</idno>
            <idno type="stamp" n="SOCIOLOGIE">SOCIOLOGIE</idno>
            <idno type="stamp" n="PARISTECH">ParisTech</idno>
            <idno type="stamp" n="PSL">Université Paris sciences et lettres</idno>
            <idno type="stamp" n="ENSMP_DEP_EMS" corresp="ENSMP">Département Economie, management et société</idno>
            <idno type="stamp" n="ENSMP_DR" corresp="ENSMP">ENSMP_DR</idno>
            <idno type="stamp" n="ENSMP-PSL" corresp="PSL">MINES ParisTech - École nationale supérieure des mines de Paris - PSL</idno>
            <idno type="stamp" n="ENSMP_I3">Collection</idno>
            <idno type="stamp" n="UMR_I3">Institut Interdisciplinaire de l'Innovation</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">War on Diseases. Patient Organizations' Problematization and Exploration of Market Issues</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Vololona</forename>
                    <surname>Rabeharisoa</surname>
                  </persName>
                  <email type="md5">b91e9a9abf2d5e1209202fa877a07534</email>
                  <email type="domain">mines-paristech.fr</email>
                  <idno type="idhal" notation="string">vololona-rabeharisoa</idno>
                  <idno type="idhal" notation="numeric">13140</idno>
                  <idno type="halauthorid" notation="string">9444-13140</idno>
                  <idno type="IDREF">https://www.idref.fr/052263576</idno>
                  <affiliation ref="#struct-445513"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Liliana</forename>
                    <surname>Doganova</surname>
                  </persName>
                  <email type="md5">d601502603a515a3decb33c65cf8226b</email>
                  <email type="domain">mines-paristech.fr</email>
                  <idno type="idhal" notation="string">liliana-doganova</idno>
                  <idno type="idhal" notation="numeric">12270</idno>
                  <idno type="halauthorid" notation="string">7885-12270</idno>
                  <idno type="IDREF">https://www.idref.fr/151853096</idno>
                  <affiliation ref="#struct-445513"/>
                </author>
              </analytic>
              <monogr>
                <title level="m">Healthcare activism. Markets, Morals, and the Collective Goods</title>
                <editor>Susi Geiger</editor>
                <imprint>
                  <publisher>Oxford University Press</publisher>
                  <biblScope unit="pp">55-85</biblScope>
                  <date type="datePub">2021</date>
                </imprint>
              </monogr>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <keywords scheme="author">
                <term xml:lang="en">pharmaceutical pricing</term>
                <term xml:lang="en">war on disease</term>
                <term xml:lang="en">evidence-based activism</term>
                <term xml:lang="en">fair price</term>
                <term xml:lang="en">rare diseases</term>
                <term xml:lang="en">healthcare activism</term>
                <term xml:lang="en">patient organizations</term>
              </keywords>
              <classCode scheme="halDomain" n="shs.socio">Humanities and Social Sciences/Sociology</classCode>
              <classCode scheme="halTypology" n="COUV">Book sections</classCode>
              <classCode scheme="halOldTypology" n="COUV">Book sections</classCode>
              <classCode scheme="halTreeTypology" n="COUV">Book sections</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Why and how do patient organizations intervene into debates on the pricing of drugs? This chapter refreshes our understanding of these two questions by situating patient organizations’ participation in drug pricing discussions into the broader dynamics of patient activism. That patient organizations look for a “fair price” is undisputable. From their point of view, though, a “fair price” is not necessarily a “low price.” Patient organizations reflect on whether or not the prices of drugs account for individual and collective concerns they deem important to count. That patient organizations are eager to defend patients’ interests is equally out of doubt. However, patient organizations are not mere lobbies but play a vital epistemic role: they intervene into therapeutic development, tackle its economic impediments, and explore solutions they feel desirable or “fair” for patients and society at large.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="laboratory" xml:id="struct-445513" status="VALID">
          <idno type="IdRef">026367025</idno>
          <idno type="ROR">https://ror.org/00a8p0m24</idno>
          <orgName>Centre de Sociologie de l'Innovation i3</orgName>
          <orgName type="acronym">CSI i3</orgName>
          <date type="start">1967-01-01</date>
          <desc>
            <address>
              <addrLine>60 Boulevard Saint Michel 75006 PARIS</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-301492" type="direct"/>
            <relation active="#struct-564132" type="indirect"/>
            <relation active="#struct-1159016" type="direct"/>
            <relation name="UMR9217" active="#struct-441569" type="indirect"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-301492" status="VALID">
          <idno type="IdRef">026375249</idno>
          <idno type="ROR">https://ror.org/04y8cs423</idno>
          <orgName>Mines Paris - PSL (École nationale supérieure des mines de Paris)</orgName>
          <date type="start">1783-01-01</date>
          <desc>
            <address>
              <addrLine>60, boulevard Saint-Michel 75006 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.minesparis.psl.eu/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-564132" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-564132" status="VALID">
          <idno type="IdRef">241597595</idno>
          <idno type="ISNI">0000 0004 1784 3645</idno>
          <idno type="ROR">https://ror.org/013cjyk83</idno>
          <orgName>Université Paris Sciences et Lettres</orgName>
          <orgName type="acronym">PSL</orgName>
          <desc>
            <address>
              <addrLine>60 rue Mazarine 75006 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.psl.eu/</ref>
          </desc>
        </org>
        <org type="regrouplaboratory" xml:id="struct-1159016" status="VALID">
          <idno type="IdRef">193951878</idno>
          <idno type="RNSR">201521699A</idno>
          <idno type="Wikidata">Q47531699</idno>
          <orgName>Institut interdisciplinaire de l’innovation</orgName>
          <orgName type="acronym">I3</orgName>
          <date type="start">2015-01-01</date>
          <desc>
            <address>
              <addrLine>828 boulevard des Maréchaux, 91762 Palaiseau Cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://i3.cnrs.fr/</ref>
          </desc>
          <listRelation>
            <relation name="UMR9217" active="#struct-441569" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-441569" status="VALID">
          <idno type="IdRef">02636817X</idno>
          <idno type="ISNI">0000000122597504</idno>
          <idno type="ROR">https://ror.org/02feahw73</idno>
          <orgName>Centre National de la Recherche Scientifique</orgName>
          <orgName type="acronym">CNRS</orgName>
          <date type="start">1939-10-19</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.cnrs.fr/</ref>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>